Operating Segments and Related Information (Tables)

9 Months Ended

Sep. 30, 2013

Operating Segments and Related Information [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following table presents certain continuing operating division information in accordance with the provisions of ASC 280, Segments Reporting.

(in thousands)	Solar			Biomedical			Consolidated
For the three months ended September 30, 2013
Net sales and revenues	$	2,445		$	1,709		4,154
Operating loss from continuing operations	$	(1,462	)	$	(749	)	(2,211		)
For the three months ended September 30, 2012
Net sales and revenues	$	2,485		$	1,743		4,228
Operating income (loss) from continuing operations	$	(2,197	)	$	179		(2,018		)
For the nine months ended September 30, 2013
Net sales and revenues	$	5,783		$	5,183		$	10,966
Operating loss from continuing operations	$	(6,192	)	$	(389	)	$	(6,581	)
For the nine months ended September 30, 2012
Net sales and revenues	$	13,219		$	5,104		$	18,323
Operating income (loss) from continuing operations	$	(5,740	)	$	326		$	(5,414	)

Revenues By Geography [Table Text Block]

The following table shows net sales and revenues by geographic area (based on customer location):

	Three Months Ended September 30,								Nine Months Ended September 30,
(in thousands)	2013		%		2012		%		2013		%		2012		%
United States	$	3,042	73	%	$	3,005	71	%	$	7,576	69	%	$	7,955	43	%
Europe/Africa	874		21		376		9		1,664		15		3,062		17
Asia	238		6		839		20		1,509		14		7,246		40
Rest of the world	—		—		8		—		217		2		60		—
	$	4,154	100	%	$	4,228	100	%	$	10,966	100	%	$	18,323	100	%